Management of established coronary artery disease in aircrew with previous myocardial infarction or revascularisation.


Journal

Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087

Informations de publication

Date de publication:
01 2019
Historique:
received: 17 03 2018
revised: 03 06 2018
accepted: 11 06 2018
entrez: 15 11 2018
pubmed: 15 11 2018
medline: 19 6 2020
Statut: ppublish

Résumé

This manuscript focuses on the broad aviation medicine considerations that are required to optimally manage aircrew with established coronary artery disease (CAD) without myocardial infarction (MI) or revascularisation (both pilots and non-pilot aviation professionals). It presents expert consensus opinion and associated recommendations and is part of a series of expert consensus documents covering all aspects of aviation cardiology.Aircrew may present with MI (both ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI)) as the initial presenting symptom of obstructive CAD requiring revascularisation. Management of these individuals should be conducted according to published guidelines, ideally with consultation between the cardiologist, surgeon and aviation medical examiner. Return to restricted flight duties is possible in the majority of aircrew; however, they must have normal cardiac function, acceptable residual disease burden and no residual ischaemia. They must also be treated with aggressive cardiac risk factor modification. Aircrew should be restricted to dual pilot operations in non-high-performance aircraft, with return to flying no sooner than 6 months after the event. At minimum, annual follow-up with routine non-invasive cardiac evaluation is recommended.

Identifiants

pubmed: 30425084
pii: heartjnl-2018-313055
doi: 10.1136/heartjnl-2018-313055
pmc: PMC6256305
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

s31-s37

Informations de copyright

© Author(s) (or their employer(s)) 2018. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

J Am Coll Cardiol. 1986 Dec;8(6):1318-24
pubmed: 3491099
JACC Cardiovasc Interv. 2009 Apr;2(4):321-8
pubmed: 19463444
Heart. 2019 Jan;105(Suppl 1):s25-s30
pubmed: 30425083
Lancet. 2013 Feb 23;381(9867):629-38
pubmed: 23439102
Ann Thorac Surg. 2011 Nov;92(5):1695-701; discussion 1701-2
pubmed: 21939958
Aviat Space Environ Med. 1996 Oct;67(10):990-6
pubmed: 9025823
Eur J Cardiothorac Surg. 2008 Mar;33(3):349-54
pubmed: 18249128
Can J Cardiol. 2006 Apr;22(5):399-404
pubmed: 16639475
J Am Coll Cardiol. 2015 Mar 17;65(10):963-72
pubmed: 25766941
N Engl J Med. 2013 Apr 11;368(15):1446-7
pubmed: 23473397
Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99
pubmed: 24222015
Circulation. 2011 Nov 29;124(22):2458-73
pubmed: 22052934
JACC Cardiovasc Interv. 2017 Jul 24;10(14):1405-1412
pubmed: 28668311
JAMA. 2014 Nov 19;312(19):2019-27
pubmed: 25399277
Lancet. 2011 Jun 25;377(9784):2193-204
pubmed: 21665265
J Am Coll Cardiol. 2010 Jun 8;55(23):2614-62
pubmed: 20513610
Am Heart J. 1994 Mar;127(3):509-13
pubmed: 8122596
N Engl J Med. 2013 Sep 19;369(12):1115-23
pubmed: 23991625
J Interv Cardiol. 2012 Oct;25(5):460-8
pubmed: 22758203
Cardiovasc Res. 2010 Dec 1;88(3):512-9
pubmed: 20581004
Circulation. 1998 Nov 3;98(18):1860-8
pubmed: 9799205
Curr Opin Cardiol. 2013 Nov;28(6):646-53
pubmed: 24077604
N Engl J Med. 2011 Nov 24;365(21):1980-9
pubmed: 22077909
Eur Heart J. 2012 Jul;33(13):1635-701
pubmed: 22555213
J Invasive Cardiol. 1994 Jul-Aug;6(6):202-8
pubmed: 10155070
J Intern Med. 2003 Mar;253(3):253-62
pubmed: 12603492
J Am Coll Cardiol. 2017 May 2;69(17):2212-2241
pubmed: 28291663
J Am Coll Cardiol. 1984 Sep;4(3):445-53
pubmed: 6147368
Int J Cardiol. 2004 Nov;97(2):327
pubmed: 15458708
N Engl J Med. 2015 Mar 26;372(13):1204-12
pubmed: 25774645
J Am Coll Cardiol. 2007 Jan 16;49(2):227-37
pubmed: 17222734
J Am Coll Cardiol. 2003 Feb 19;41(4):521-8
pubmed: 12598059
N Engl J Med. 2014 Dec 4;371(23):2155-66
pubmed: 25399658
Eur J Cardiothorac Surg. 2012 Apr;41(4):763-9
pubmed: 22219402
Can J Cardiol. 2003 Jun;19(7):802-8
pubmed: 12813614
Eur J Cardiothorac Surg. 2009 Apr;35(4):658-70
pubmed: 19231230
Medicine (Baltimore). 2016 Jan;95(1):e2068
pubmed: 26735525
Arch Intern Med. 1997 Apr 28;157(8):865-9
pubmed: 9129546
Eur Heart J. 1992 Dec;13 Suppl H:89-95
pubmed: 1493834
J Am Coll Cardiol. 2017 Jun 27;69(25):3055-3066
pubmed: 28412389
Eur J Cardiothorac Surg. 2011 Aug;40(2):399-404
pubmed: 21236696
J Am Coll Cardiol. 2010 Jul 20;56(4):254-63
pubmed: 20633817
JACC Cardiovasc Interv. 2017 Mar 13;10(5):462-473
pubmed: 28279314
N Engl J Med. 2017 May 4;376(18):1713-1722
pubmed: 28304224
JAMA. 2012 Sep 12;308(10):998-1006
pubmed: 22928184
Eur Heart J. 2007 Jun;28(12):1409-17
pubmed: 17412730
Clin Cardiol. 1997 Dec;20(12):993-8
pubmed: 9422836

Auteurs

Eddie D Davenport (ED)

Aeromedical Consult Service, United States Air Force School of Aerospace Medicine, Wright-PAtterson AFB, Ohio, USA.

Thomas Syburra (T)

Cardiac Surgery Department, Luzerner Kantonsspital, Luzern, Switzerland.

Gary Gray (G)

Canadian Forces Environmental Medical Establishment, Toronto, Ontario, Canada.

Rienk Rienks (R)

Department of Cardiology, University Medical Center Utrecht and Central Military Hospital, Utrecht, The Netherlands.

Dennis Bron (D)

Aeromedical Centre, Swiss Air Force, Zürich, Switzerland.

Olivier Manen (O)

Aviation Medicine Department, AeMC, Percy Military Hospital, Clamart, France.

Joanna d'Arcy (J)

Royal Air Force Aviation Clinical Medicine Service, RAF Centre of Aviation Medicine, RAF Henlow, Bedford, UK.

Norbert J Guettler (NJ)

German Air Force Center for Aerospace Medicine, Fuerstenfeldbruck, Germany.

Edward D Nicol (ED)

Royal Air Force Aviation Clinical Medicine Service, RAF Centre of Aviation Medicine, RAF Henlow, Bedford, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH